scholarly journals Production of clavulanic acid and cephamycin C by Streptomyces clavuligerus under different fed-batch conditions

2013 ◽  
Vol 30 (2) ◽  
pp. 257-266 ◽  
Author(s):  
C. Bellão ◽  
T. Antonio ◽  
M. L. G. C. Araujo ◽  
A. C. Badino
2002 ◽  
Vol 184 (11) ◽  
pp. 3106-3113 ◽  
Author(s):  
Irene Santamarta ◽  
Antonio Rodríguez-García ◽  
Rosario Pérez-Redondo ◽  
Juan F. Martín ◽  
Paloma Liras

ABSTRACT The putative regulatory CcaR protein, which is encoded in the β-lactam supercluster of Streptomyces clavuligerus, has been partially purified by ammonium sulfate precipitation and heparin affinity chromatography. In addition, it was expressed in Escherichia coli, purified as a His-tagged recombinant protein (rCcaR), and used to raise anti-rCcaR antibodies. The partially purified CcaR protein from S. clavuligerus was able to bind DNA fragments containing the promoter regions of the ccaR gene itself and the bidirectional cefD-cmcI promoter region. In contrast, CcaR did not bind to DNA fragments with the promoter regions of other genes of the cephamycin-clavulanic acid supercluster including lat, blp, claR, car-cyp, and the unlinked argR gene. The DNA shifts obtained with CcaR were prevented by anti-rCcaR immunoglobulin G (IgG) antibodies but not by anti-rabbit IgG antibodies. ccaR and the bidirectional cefD-cmcI promoter region were fused to the xylE reporter gene and expressed in Streptomyces lividans and S. clavuligerus. These constructs produced low catechol dioxygenase activity in the absence of CcaR; activity was increased 1.7- to 4.6-fold in cultures expressing CcaR. Amplification of the ccaR promoter region lacking its coding sequence in a high-copy-number plasmid in S. clavuligerus ATCC 27064 resulted in a reduced production of cephamycin C and clavulanic acid, by 12 to 20% and 40 to 60%, respectively, due to titration of the CcaR regulator. These findings confirm that CcaR is a positively acting autoregulatory protein able to bind to its own promoter as well as to the cefD-cmcI bidirectional promoter region.


2005 ◽  
Vol 22 (4) ◽  
pp. 557-563 ◽  
Author(s):  
A. B. Neto ◽  
D. B. Hirata ◽  
L. C. M. Cassiano Filho ◽  
C. Bellão ◽  
A. C. Badino Júnior ◽  
...  

2002 ◽  
Vol 18 (3) ◽  
pp. 451-457 ◽  
Author(s):  
J.A. Roubos ◽  
P. Krabben ◽  
W.T.A.M. de Laat ◽  
R. Babuska ◽  
J.J. Heijnen

2001 ◽  
Vol 67 (5) ◽  
pp. 2292-2297 ◽  
Author(s):  
A. S. Paradkar ◽  
R. H. Mosher ◽  
C. Anders ◽  
A. Griffin ◽  
J. Griffin ◽  
...  

ABSTRACT Cephamycin C production was blocked in wild-type cultures of the clavulanic acid-producing organism Streptomyces clavuligerus by targeted disruption of the gene (lat) encoding lysine ɛ-aminotransferase. Specific production of clavulanic acid increased in the latmutants derived from the wild-type strain by 2- to 2.5-fold. Similar beneficial effects on clavulanic acid production were noted in previous studies when gene disruption was used to block the production of the non-clavulanic acid clavams produced by S. clavuligerus. Therefore, mutations in lat and in cvm1, a gene involved in clavam production, were introduced into a high-titer industrial strain of S. clavuligerus to create a double mutant with defects in production of both cephamycin C and clavams. Production of both cephamycin C and non-clavulanic acid clavams was eliminated in the double mutant, and clavulanic acid titers increased about 10% relative to those of the parental strain. This represents the first report of the successful use of genetic engineering to eliminate undesirable metabolic pathways in an industrial strain used for the production of an antibiotic important in human medicine.


2005 ◽  
Vol 49 (4) ◽  
pp. 1529-1541 ◽  
Author(s):  
Dawn R. D. Bignell ◽  
Kapil Tahlan ◽  
Kimberley R. Colvin ◽  
Susan E. Jensen ◽  
Brenda K. Leskiw

ABSTRACT In Streptomyces coelicolor, bldG encodes a putative anti-anti-sigma factor that regulates both aerial hypha formation and antibiotic production, and a downstream transcriptionally linked open reading frame (orf3) encodes a putative anti-sigma factor protein. A cloned DNA fragment from Streptomyces clavuligerus contained an open reading frame that encoded a protein showing 92% identity to the S. coelicolor BldG protein and 91% identity to the BldG ortholog in Streptomyces avermitilis. Sequencing of the region downstream of bldG in S. clavuligerus revealed the presence of an open reading frame encoding a protein showing 72 and 69% identity to the ORF3 proteins in S. coelicolor and S. avermitilis, respectively. Northern analysis indicated that, as in S. coelicolor, the S. clavuligerus bldG gene is expressed as both a monocistronic and a polycistronic transcript, the latter including the downstream orf3 gene. High-resolution S1 nuclease mapping of S. clavuligerus bldG transcripts revealed the presence of three bldG-specific promoters, and analysis of expression of a bldGp-egfp reporter indicated that the bldG promoter is active at various stages of development and in both substrate and aerial hyphae. A bldG null mutant was defective in both morphological differentiation and in the production of secondary metabolites, such as cephamycin C, clavulanic acid, and the 5S clavams. This inability to produce cephamycin C and clavulanic acid was due to the absence of the CcaR transcriptional regulator, which controls the expression of biosynthetic genes for both secondary metabolites as well as the expression of a second regulator of clavulanic acid biosynthesis, ClaR. This makes bldG the first regulatory protein identified in S. clavuligerus that functions upstream of CcaR and ClaR in a regulatory cascade to control secondary metabolite production.


Sign in / Sign up

Export Citation Format

Share Document